All Dr Vibha Jawa articles
-
NewsImpurities findings could enhance peptide drug safety
EpiVax and Cubrc research supports FDA guidance on impurity risk assessment in generic peptides.
EpiVax and Cubrc research supports FDA guidance on impurity risk assessment in generic peptides.